CMT stem cell treatment in Western countries can cost up to $50,000. Colombian medical centers provide the same advanced therapy at $5,000 to $15,000. The 50-70% price difference makes Colombia a prime destination for patients seeking stem cell treatments. Regencord stands out by creating individual-specific treatment plans that include detailed evaluations and custom therapies for each patient’s needs.
Our 2025 price breakdown shows everything about CMT stem cell treatment costs at Regencord. Patients can learn treatment choices, what affects pricing, and what they should expect during their trip to Pereira. The information about treatment success rates and recovery care will help readers decide if this healthcare investment suits their needs.
“I am pro-life. I believe human life begins at conception. I also believe that embryonic stem cell research should be encouraged and supported.” — Orrin Hatch, Former U.S. Senator from Utah
Charcot-Marie-Tooth Disease (CMT) affects about 1 in 2,500 Americans. It’s the most common inherited peripheral neuropathy worldwide. The disease affects the nerves that connect the brain and spinal cord to the rest of the body, causing people to lose muscle tissue and sensation over time.
Scientists have found mutations in over 100 different genes that create various subtypes of CMT, each with its own characteristics. The disease affects either the axon (the signal-sending part of the nerve) or the myelin sheath (the protective covering around nerves), disrupting how signals travel through the peripheral nervous system.
Damaged myelin or axons cause nerve signals to slow down, weaken, or stop completely. People often experience muscle weakness that starts in their feet and lower legs. The weakness then spreads to their hands and arms. Other symptoms include:
Most people notice their first symptoms between ages 5 and 15, though they can appear at any age. Without treatment, these symptoms get worse as time passes.
New discoveries in stem cell research give hope to CMT patients. Mesenchymal stem cells (MSCs) have shown they can boost myelin production and help peripheral nerves work better. These cells help in several ways:
A recent clinical trial tested EN001, a mesenchymal stem cell therapy, and showed good results for CMT1A patients. After 16 weeks, patients' CMT Neuropathy Scores dropped by an average of 2.89 points. Higher doses worked better, and some patients' conditions improved from severe to moderate or moderate to mild.
Regencord's team in Colombia has created special protocols to treat neurological conditions like CMT. They use stem cells' healing properties to fix nerve damage and help patients live better lives. Their treatments work to:
Regencord has treated more than 5,000 patients worldwide over the past decade. They offer complete care throughout the treatment process. Their focus on patient care includes expert medical advice and ongoing support to help patients get the best results from their CMT stem cell treatment.
Patients often find it challenging to understand the financial side of stem cell therapy for CMT treatment. Regencord in Colombia stands out as an affordable option compared to Western facilities. They deliver quality results at better prices.
Stem cell therapy at Regencord costs around USD 6,900 for standard treatments. This makes Regencord a competitive player in the global stem cell market. Similar treatments in the United States can cost USD 50,000 or more. The base package has:
Regencord's prices reflect its quality standards. It follows ISO 9001 management systems and ISO 13022 risk management protocols.
Regencord has several extra services that might affect your final cost:
These services come in complete care packages. Packages offer better value than buying services separately.
Regencord's prices compare well to those of other Colombian facilities. Their base price of USD 6,900 is at the lower end of Colombia's stem cell therapy range. Most clinics charge between USD 5,000 and USD 20,000. Still, Regencord's pricing reflects its ISO-certified facilities. It doesn't cut corners to lower its rates.
Your CMT treatment's total cost depends on several important factors:
These factors help you set realistic budget expectations for your treatment experience at Regencord.
Regencord welcomes CMT patients to a well-laid-out medical experience that maximizes therapeutic outcomes. The facility sits in Colombia’s beautiful Eje Cafetero (Coffee Region). Patients receive complete care from their original consultation through post-treatment follow-up.
Your Regencord experience starts with a full medical assessment. Our specialists review your complete medical history and perform physical examinations. They may request imaging studies to review the severity of CMT symptoms. This complete review helps physicians determine treatment eligibility. They create individual-specific therapy plans based on your specific CMT subtype and symptom profile.
The treatment process follows a systematic protocol after your review:
This dual-application approach makes shared delivery of stem cells possible. It targets affected nerve tissues through direct delivery to the central nervous system and systemic circulation.
Patients stay under observation for about two days after treatment. Some experience mild to moderate neck stiffness and headaches. These symptoms respond well to non-NSAID pain medications. Patients receive prescriptions for supplements including adenosine triphosphate, uridine, and cytidine monophosphate. These supplements help nerve regeneration. Monthly follow-ups track progress. Most important improvements become noticeable around the 10-month mark.
Pereira's Matecaña International Airport connects to over 500 global destinations, including New York and Miami. Patients can choose from several hotels, such as Movich Hotel, Sonesta Hotel, and Visus Hotel. The region's mild climate creates perfect conditions for recovery year-round. Lush landscapes provide a peaceful healing environment that stands apart from typical medical facilities.
“This report highlights the successful treatment of a Charcot–Marie–Tooth disease case using the Regentime stem cell procedure, suggesting its potential as a promising therapeutic approach for patients suffering from this challenging condition.” — Researchers from Samsung Medical Center, Medical researchers studying stem cell treatments for CMT
Clinical studies continue to show that stem cell therapy works for Charcot-Marie-Tooth disease. Recent research reveals measurable improvements in many symptoms.
Mesenchymal stem cell therapy offers the most important benefits to patients with CMT1A, the most common form. A recent clinical trial showed that patients’ CMT Neuropathy Score dropped by 2.89 points in just 16 weeks. Higher doses led to even better results—a 3.50-point reduction. Many patients moved from severe to moderate or moderate to mild disease categories.
Other CMT types typically show these improvements:
EN001, a specialized mesenchymal stem cell therapy, shows great promise for targeting and regenerating damaged nerves and muscles.
Patients follow a predictable recovery pattern after CMT stem cell treatment:
Original phase (first few weeks): Less inflammation and pain. Middle phase (3-6 months): Better function and fewer symptoms. Long-term phase (6+ months): Full benefits emerge, especially in severe cases
One case study revealed that after 10 months, a patient who needed help walking could walk normally again with restored sensation. The patient's patellar and Achilles tendon reflexes returned to normal, and their Overall Neuropathy Limitations Score dropped to 0/12.
Real patient stories provide the most compelling evidence. A 19-year-old male diagnosed with CMT at age 12 struggled with worsening sensory-motor neuropathy and needed help to walk. Ten months after stem cell therapy, he could "feel stronger and perform daily activities with ease."
The EN001 clinical trial participants showed similar success. They performed better in practical mobility tests like the 10-meter Walking Test, Functional Disability Scale, and nerve conduction studies.
Stem cell treatment for CMT disease represents a groundbreaking therapy that brings new hope to patients looking for real solutions. Clinical trials and research data show remarkable improvements in patients’ mobility, nerve function, and quality of life. Regencord delivers this advanced treatment at prices much lower than Western facilities that charge up to $50,000 while meeting international quality standards.
The success stories speak volumes. Patients show lower CMT Neuropathy Scores, and many regain their ability to walk within 10 months. Scientific evidence and successful case studies prove this treatment works well for CMT types of all kinds. Regencord’s specialized protocols and complete care help patients get the best results during their recovery.
Patients need to consider several things when choosing stem cell treatment—costs, treatment methods, and likely outcomes matter greatly. Regencord stands out as a trusted choice with clear pricing, ISO-certified facilities, and proven success rates. Their Pereira location gives patients easy access and a perfect setting to recover. You get world-class treatment that delivers results without breaking the bank.
Stem cells are unique cells with the ability to develop into various cell types and repair damaged tissues. They are used in regenerative medicine, including treatments for cancer, neurodegenerative diseases, and injuries. Sources include bone marrow, cord blood, and embryos.
+1 888-540-4101